title: Inconsistencies in cardiovascular data from COX-2 inhibitor trials--is it a class effect?
authors.forename: Mark
authors.initials: M
authors.lastname: Weatherall
authors.forename: Sarah
authors.initials: S
authors.lastname: Aldington
authors.forename: Brent
authors.initials: B
authors.lastname: Caldwell
authors.forename: Richard
authors.initials: R
authors.lastname: Beasley
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D002986:Clinical Trials as Topic; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects*; D003625:Data Collection; D006801:Humans; D011379:Prognosis
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors